97028 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants
LRRC8 proteins and protein complexes and methods for identification of channel modulators
#2102Antibody modulators of APLNR
#2103Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#2104Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
#2105Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
#2106Diagnostic method for detecting an autoimmune disease
#2107Broad spectrum ErBB ligand binding molecules and methods for preparing and using them
#2108Calcium-activated chloride channel involved in human sweat formation
#2109Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#2110Protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair
#2111HIGH-EFFICIENCY, SODIUM -SPECIFIC, BLUE-SHIFTED CHANNELRHODOPSINS
#2112Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif
#2113Chimeric NK receptor and methods for treating cancer
#2114Methods for detecting and monitoring endocrine disrupting chemicals (EDCs)
#2115Cell line, system and method for optical control of secondary messengers
#2116Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
#2117Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto
#2118Method and composition for crystallizing G protein-coupled receptors
#2119EXON REPLACEMENT WITH STABILIZED ARTIFICIAL RNAS
#2120Albumin fusion proteins
#2121Compositions and methods for treating hypertension
#2122Compounds and methods for modulating pharmacokinetics
#2123AAV mediated aquaporin gene transfer to treat Sjogren's syndrome
#2124Differentiation marker and differentiation control of eye cell
#2125Anti-Tie2 antibodies and uses thereof
#2126Methods and compositions for modulating Toso activity
#2127Toll-like receptors
#2128Alkane exporter and its use
#2129Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
#2130Nanodisc clathrates and uses thereof
#2131Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#2132FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#2133KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCs)
#2134ANTI-PRO87299 ANTIBODIES
#2135BTNL3 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF
#2136SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT
#2137Modified polynucleotides for the production of cosmetic proteins and peptides
#2138Light-activated cation channel and uses thereof
#2139PAR4 agonist peptides
#2140Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
#2141METHOD TO ENGINEER MAMMANLIAN-TYPE CARBOHYDRATE STRUCTURES
#2142Antibody that binds murine wise protein
#2143Peptide conjugates for treating pain
#2144IDENTIFICATION OF SPECIFIC APOLIPOPROTEIN EPITOPES ON CIRCULATING ATHEROGENIC LOW-DENSITY LIPOPROTEIN
#2145Optogenetic inhibition of overactive neuronal activity
#2146Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof
#2147METHOD OF IDENTIFYING FOETAL ERYTHROBLAST
#2148Compositions and methods for promoting wound healing and tissue regeneration
#2149Methods and compositions for modulating toso activity
#2150METHODS OF USING HCN GENES TO TREAT CARDIAC ARRHYTHMIAS
#2151Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#2152Dendrimer conjugates for coating cells
#2153P2X7 receptor antagonists and agonists
#2154GLUT-1 as a receptor for HTLV envelopes and its uses
#2155Polypeptide for improving protein production in microorganisms of the phylum Labyrinthulomycota
#2156Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity
#2157Antimicrobial peptide and use thereof
#2158BIOMARKER
#2159Personalized immunotherapy against several neuronal and brain tumors
#2160Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSK
#2161Modular nanodevices for smart adaptable vaccines
#2162Method For Detecting And Purifying Pancreatic Beta Cells
#2163hDC-sign binding peptides
#2164Anti-human folate receptor beta antibodies and methods of use
#2165Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies
#2166Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand
#2167Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44
#2168Use of semaphorin-4D binding molecules for treatment of atherosclerosis
#2169CHIMERIC PROTEINS FOR TREATMENT OF DISEASES
#2170Recombinant polypeptides comprising MHC class II α1 domains
#2171Repebody for novel interleukin-6 and use thereof
#2172Microorganism for expressing a human membrane protein
#2173Targeted and modular exosome loading system
#2174METHODS FOR INHIBITING OCULAR ANGIOGENESIS
#2175Immunosuppression modulating compounds
#2176HIV vpr-specific T-cell receptors
#2177COMPOSITIONS AND METHODS FOR INCREASING THE EXPRESSION AND SIGNALLING OF PROTEINS ON CELL SURFACES
#2178Methods and compositions to regulate hepcidin expression
#2179EXPRESSION CONSTRUCTS ENCODING G PROTEIN COUPLED RECEPTORS AND METHODS OF USE THEREOF
#2180Modified polynucleotides for the production of proteins
#2181MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS
#2182Methods of treating liver conditions using Notch2 antagonists
#2183Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#2184Composition and method for diagnosis and immunotherapy of lung cancer
#2185Multi-specific Fab fusion proteins comprising a CD3-binding Fab fragment with N-terminal fusion to binding domains and methods of use
#2186Electromagnetic band gap element, electronic circuit, and conductor structure
#2187Peptide increasing fusiogenic capacity of a gamete
#2188Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE
#2189GENETIC VARIANTS UNDERLYING HUMAN COGNITION AND METHODS OF USE THEREOF AS DIAGNOSTIC AND THERAPEUTIC TARGETS
#2190METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSES AND AUTOIMMUNITY
#2191Method of treating motor neuron disease with an antibody that agonizes MuSK
#2192Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods
#2193PARTIAL MHC CONSTRUCTS AND METHODS OF USE
#2194CFTR mRNA compositions and related methods and uses
#2195Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use
#2196Method for Stimulating T Cell and Use Thereof
#2197Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#2198Modulators of antiviral signaling pathways and therapeutic uses thereof
#2199Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#2200Bispecific chimeric proteins comprising DARPins
#2201CLDN5 mini-promoters
#2202Coated devices and methods for coating
#2203Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making
#2204Potent and selective inhibitors of NA1.7
#2205Toll-like receptor 2 binding epitope and binding member thereto
#2206Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
#2207Repebody against immunoglobulin G and uses thereof
#2208Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
#2209Use of ICOS-based CARs to enhance antitumor activity and CAR persistence
#2210Membrane span-kinase fusion protein and the uses thereof
#2211COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS
#2212Methods of identifying, isolating and using odorant and aroma receptors
#2213Method of treating or retarding the development of blindness
#2214Peptides and methods and uses thereof for preventing retinal disorders
#2215Use of the CD2 signaling domain in second-generation chimeric antigen receptors
#2216Sperm-specific cation channel, Catsper2, and uses therefor
#2217Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#2218Peptide compounds for inhibition of platelet aggregation
#2219Correction of Crb1 mutations
#2220Tools and methods for expression of membrane proteins
#2221Transmembrane protein as biosensors
#2222Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell
#2223Methods of enhancing genetic diagnosis
#2224Compositions and methods to modulate cell activity
#2225Biomarkers for non-hodgkin lymphomas and uses thereof
#2226High-affinity DMF5 T cell receptor (TCR) variants
#2227Dual delivery system for heterologous antigens
#2228Fusion protein for suppression of autoantibodies
#2229Methods of screening T1R1/T1R3 receptors for compounds that modulate umami taste signaling
#2230NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF
#2231Antibodies To Non-Functional P2X7 Receptor
#2232Use of fibromodulin and lumican for increasing muscle mass
#2233Methods for screening for binding partners of G-protein coupled receptors
#2234Engineered and methods of use thereof
#2235Cell culture substrate comprising a laminin and a cadherin
#2236Stable proteins
#2237MARKER FOR NEUROMYELITIS OPTICA
#2238Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors
#2239Gene and mutations thereof associated with seizure and movement disorders
#2240GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#2241Methods and compositions for treating or preventing pruritis
#2242Products useful for the treatment of malignant neoplasms of the human nervous system
#2243SOLUBLE UROKINASE RECEPTOR (SUPAR) IN DIABETIC KIDNEY DISEASE
#2244Antibacterial polymers and method for obtaining the same
#2245Protein markers associated bone marrow stem cell differentiation into early progentior cells
#2246Rod cell-specific promoter
#2247Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides
#2248METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTORS AND ADAPTORS THEREOF
#2249Methods for controlling T cell proliferation
#2250Chimeric antigen receptor specific for folate receptor β
#2251Notch agonists for the treatment of cancer
#2252Suppression of cancer
#2253Binding domains directed against GPCR:G protein complexes and uses derived thereof
#2254Compositions and methods of altering cholesterol levels
#2255Anti-CD22 chimeric antigen receptors
#2256Inhibitors of mitochondrial fission and methods of use thereof
#2257Feline bitter taste receptors and methods
#2258Human Notch1 decoys
#2259Anti-notch NRR antibodies and methods using same
#2260Polypeptides Involved In Immune Response
#2261PEPTIDE COMPOSITIONS THAT DOWNREGULATE TLR-4 SIGNALING PATHWAY AND METHODS OF PRODUCING AND USING SAME
#2262MODIFIED POLYNUCLEOTIDES ENCODING CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4
#2263Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#2264Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#2265Modified polynucleotides for treating protein deficiency
#2266Methods for reducing CD36 expression
#2267Non-hemolytic LLO fusion proteins and methods of utilizing same
#2268Use of Toll-Like Receptor agonist for treating cancer
#2269Water soluble membrane proteins and methods for the preparation and use thereof
#2270CYSTIC FIBROSIS TREATMENT
#2271Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
#2272Optically-based stimulation of target cells and modifications thereto
#2273Methods for treating neural cell swelling
#2274Methods for detection of botulinum neurotoxin
#2275Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of TM4SF4 in non-small cell lung cancer
#2276POLYNUCLEOTIDE, POLYPEPTIDE, ANIMAL MODEL AND METHOD FOR THE DEVELOPMENT OF COMPLEMENT SYSTEM MODULATORS
#2277Nogo receptor antagonists and methods of increasing neurite outgrowth
#2278Communicating a targeted message to a wireless device based on location and two user profiles
#2279Modified polynucleotides for treating galactosylceramidase protein deficiency
#2280Methods and compositions for treating pain
#2281LRP1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (VLDL) to ischaemic cardiac muscle
#2282Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#2283Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#2284Immunity to folate receptors
#2285T cell receptors and related materials and methods of use
#2286IL4/IL13 binding repeat proteins and uses
#2287Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#2288Modified polynucleotides encoding basic helix-loop-helix family member E41
#2289Aquaporin-4 peptide compositions and methods of use thereof
#2290Protein involved in detection of cancer metastasis and a treatment thereof
#2291COMPOSITIONS COMPRISING AGENTS THAT INHIBIT NEUROPILIN AND TOLLOID LIKE 2
#2292Method and composition for crystallizing G protein-coupled receptors
#2293Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#2294Membrane transporter NaPi2b (SCL34A2) epitope antibodies
#2295Multimeric constructs
#2296Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#2297Methods for purifying insect membrane-bound receptor proteins from recombinant production hosts
#2298Inhibition of inflammation using antagonists of MUC1
#2299Modified polynucleotides encoding citeD4
#2300Immunotherapy with binding agents
#2301SOLUBLE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF
#2302Nogo Receptor-Mediated Blockade of Axonal Growth
#2303ROLE OF PROTEOGLYCANS IN DRUG DEPENDENCE
#2304Light-sensitive chimeric GPCR protein
#2305Mutant sodium channel Nav1.7 and methods related thereto
#2306Phoenixin peptides
#2307GPCR comprising an IC2 insertion
#2308Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
#2309Methods of promoting CNS neuronal repair by inhibiting LRP-1
#2310EGFR and C-Met fibronectin type III domain binding molecules
#2311EGFR and c-Met fibronectin type III domain binding molecules
#2312Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#2313Peptides capable of modulating the function of TIRC7
#2314Compositions and methods for treating, diagnosing and monitoring disease
#2315Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#2316Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment
#2317Modified polynucleotides encoding septin-4
#2318GENERATION OF ANTIGEN SPECIFIC T CELLS
#2319Peptides for inducing antibodies to a non-functional P2Xreceptor
#2320Bis-sulfhydryl macrocyclization systems
#2321Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof
#2322EphA2 T-cell epitope agonists and uses therefore
#2323HBV EPITOPE REACTIVE EXOGENOUS T CELL RECEPTOR (TCR) AND USES THEREOF
#2324PHOTOACTIVATABLE RECEPTORS AND THEIR USES
#2325Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#2326Compositions and methods for assessing and treating adrenal diseases and disorders
#2327Drug Screening Target For Alzheimer's Disease and Method of Screening Potential Drugs
#2328Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
#2329Method for identifying compounds that modulate a T2R taste receptor
#2330Stimulation of Arterial Collateral Growth and Lymphogenesis
#2331Modified polynucleotides encoding granulysin
#2332Modified polynucleotides encoding apoptosis inducing factor 1
#2333Modified polynucleotides encoding hepatitis A virus cellular receptor 2
#2334Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
#2335Modified polynucleotides encoding aquaporin-5
#2336Nucleic acid molecules encoding non-naturally occurring T cell receptors and cells thereof
#2337Mouse for predicting a behavior of drugs in humans
#2338Human Salty Taste Receptor And Methods Of Modulating Salty Taste Perception
#2339Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists
#2340Water-soluble polypeptides comprised of repeat modules, method for preparing the same and method for a target-specific polypeptide and analysis of biological activity thereof
#2341Pepducin design and use
#2342Glycosylated specificity exchangers
#2343Means and methods for diagnosing and treating multiple sclerosis
#2344ANTI-TUMOR ANTIBODY-TUMOR SUPPRESSOR FUSION PROTEIN COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF CANCER
#2345Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
#2346Bruton's tyrosine kinase as anti-cancer drug target
#2347Targeting complement factor H for treatment of diseases
#2348Fusion proteins comprising an engineered knottin peptide and uses thereof
#2349Method for producing sheet-like pancreatic islet
#2350Novel Genes Encoding Proteins Having Prognostic, Diagnostic, Preventive, Therapeutic, and Other Uses
#2351Antibodies that specifically bind SOST and WISE peptides
#2352Membrane protein expression vector comprising major envelope protein P9 of systovirus PHI12 as a fusion partner and method for producing membrane protein using the same
#2353G-protein coupled receptor polypeptides involved in sensory transduction
#2354Inhibition of AXL signaling in anti-metastatic therapy
#2355Muteins of human lipocalin 2 with affinity for CTLA-4
#2356Methods and compositions for modulating T cell and/or B cell activation
#2357Compositions and methods for treating cancer
#2358Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis
#2359Genetically engineered mouse model for autism spectrum disorder having deletion of gene and use thereof
#2360Methods and composition for measuring the amount of vitamin D derivatives
#2361Compositions and methods for promoting wound healing and tissue regeneration
#2362Codon optimized sodium-iodide symporter gene and its use
#2363Method for treating cancer using an antibody that inhibits notch4 signaling
#2364Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease
#2365Yeast cell surface display of proteins and uses thereof
#2366Methods and compositions for gamma-secretase assay
#2367System and method for monitoring and analyzing internet traffic
#2368Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1
#2369TOMM34 peptides and vaccines including the same
#2370METHOD FOR TREATING SOLID TUMORS
#2371Peptide library production method, peptide library, and screening method
#2372Immunotherapy against ErbB-3 receptor
#2373Botulinum neurotoxin a receptor and the use thereof
#2374Method for regulating neurite growth
#2375Treatment with factor ix-albumin fusion protein
#2376E518A/K mutant smoothened and methods of using the same
#2377Treatment with factor VII-albumin fusion protein
#2378Polypeptides derived from calcitonin receptors and methods of use
#2379T1R taste receptors and genes encoding same
#2380Metabolic diseases-related odorant receptor genes and use thereof
#2381Cell division marker
#2382NOTCH inhibition in the treatment of cardiovascular disease
#2383Cell line, system and method for optical control of secondary messengers
#2384PAR1 and PAR2 c-tail peptides and peptide mimetics
#2385ANTI-SYNDECAN-4 ANTIBODIES
#2386Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
#2387SMOOTHENED POLYPEPTIDES AND METHODS OF USE
#2388Methods and compositions for screening and treating developmental disorders
#2389Delivering polypeptides to phagocytes
#2390METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES
#2391Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
#2392METHOD OF TREATING ABNORMAL ANGIOGENESIS VIA THE BAI FAMILY OF PROTEINS AND THEIR PROTEIN FRAGMENTS
#2393Methods of screening T1R1/T1R3 receptors for compounds that modulate umami taste signaling
#2394COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF KREMEN AND OR WNT
#2395Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucleic acids encoding the same
#2396Optically-based stimulation of target cells and modifications thereto
#2397High affinity HIV T cell receptors
#2398PAR4 agonist peptides
#2399Variant activin receptor polypeptides and uses thereof
#2400Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof